Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$209.01 - $232.56 $92,173 - $102,558
441 Added 4.1%
11,208 $2.45 Million
Q4 2023

Feb 14, 2024

BUY
$197.69 - $227.29 $215,284 - $247,518
1,089 Added 11.25%
10,767 $2.45 Million
Q3 2023

Nov 16, 2023

BUY
$201.05 - $221.7 $285,088 - $314,370
1,418 Added 17.17%
9,678 $1.95 Million
Q2 2023

Jul 21, 2023

SELL
$211.93 - $241.33 $776,511 - $884,233
-3,664 Reduced 30.73%
8,260 $1.99 Million
Q1 2023

May 15, 2023

BUY
$213.32 - $257.83 $811,255 - $980,527
3,803 Added 46.83%
11,924 $2.74 Million
Q4 2022

Feb 10, 2023

BUY
$203.72 - $248.97 $77,006 - $94,110
378 Added 4.88%
8,121 $1.91 Million
Q3 2022

Nov 03, 2022

BUY
$204.81 - $262.19 $37,070 - $47,456
181 Added 2.39%
7,743 $1.59 Million
Q2 2022

Aug 15, 2022

BUY
$213.86 - $277.87 $104,577 - $135,878
489 Added 6.91%
7,562 $1.77 Million
Q1 2022

May 16, 2022

BUY
$259.82 - $298.18 $77,946 - $89,454
300 Added 4.43%
7,073 $1.87 Million
Q4 2021

Feb 11, 2022

BUY
$271.6 - $314.21 $51,332 - $59,385
189 Added 2.87%
6,773 $2.13 Million
Q3 2021

Nov 10, 2021

BUY
$274.82 - $308.34 $69,254 - $77,701
252 Added 3.98%
6,584 $1.85 Million
Q2 2021

Aug 04, 2021

SELL
$251.87 - $278.14 $19,645 - $21,694
-78 Reduced 1.22%
6,332 $1.75 Million
Q1 2021

Apr 30, 2021

SELL
$204.88 - $255.03 $6,556 - $8,160
-32 Reduced 0.5%
6,410 $1.64 Million
Q4 2020

Jan 29, 2021

SELL
$186.91 - $214.42 $14,578 - $16,724
-78 Reduced 1.2%
6,442 $1.31 Million
Q3 2020

Nov 05, 2020

BUY
$167.03 - $201.3 $338,903 - $408,437
2,029 Added 45.18%
6,520 $1.23 Million
Q2 2020

Jul 23, 2020

SELL
$113.31 - $182.44 $64,926 - $104,538
-573 Reduced 11.32%
4,491 $746,000
Q1 2020

May 05, 2020

SELL
$104.32 - $195.28 $109,536 - $205,044
-1,050 Reduced 17.17%
5,064 $640,000
Q4 2019

Jan 30, 2020

BUY
$163.48 - $173.61 $16,184 - $17,187
99 Added 1.65%
6,114 $1.03 Million
Q3 2019

Nov 01, 2019

BUY
$159.77 - $178.1 $72,695 - $81,035
455 Added 8.18%
6,015 $1.01 Million
Q2 2019

Jul 26, 2019

BUY
$144.16 - $172.9 $43,680 - $52,388
303 Added 5.76%
5,560 $961,000
Q1 2019

Apr 24, 2019

SELL
$123.7 - $156.3 $325,083 - $410,756
-2,628 Reduced 33.33%
5,257 $804,000
Q4 2018

Feb 01, 2019

SELL
$120.82 - $174.09 $87,352 - $125,867
-723 Reduced 8.4%
7,885 $996,000
Q3 2018

Oct 25, 2018

SELL
$167.67 - $188.27 $112,003 - $125,764
-668 Reduced 7.2%
8,608 $1.5 Million
Q2 2018

Jul 20, 2018

BUY
$160.33 - $189.41 $208,909 - $246,801
1,303 Added 16.34%
9,276 $1.67 Million
Q1 2018

Apr 18, 2018

BUY
$161.53 - $178.11 $87,710 - $96,713
543 Added 7.31%
7,973 $1.29 Million
Q4 2017

Jan 17, 2018

BUY
$147.99 - $163.95 $150,505 - $166,737
1,017 Added 15.86%
7,430 $1.19 Million
Q3 2017

Oct 17, 2017

BUY
$149.47 - $160.56 $958,551 - $1.03 Million
6,413
6,413 $968,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.